The frequency of EGFR activation mutations may vary from population to population, ranging from around 10% to 15% in Caucasian NSCLC populations [6]; in Asian NSCLC populations, the frequency of EGFR activation mutations is around 30% to 50%. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.